Declutter the Data in your Clinical Trial: Mitigate Risk Before it Becomes an Issue
April 29, 2020 11 am EST / 8 am PST | Medidata

Bridging data from disparate systems without compromising data quality is a crucial component of clinical trials—of all sizes. Sometimes these efforts are manual, time-consuming, and riddled with oversight which, ultimately, delay successful deployments of clinical trials at a high cost.  Register for the webinar to learn how to proactively detect issues and remediate efficiently.

Successful Clinical Trials in the Era of Genetics-based Medicine
April 28, 2020 2p.m. EST / 11 a.m. PST | InformedDNA

In this webinar, we'll explore how to address and overcome challenges in genetics-based clinical trials, using real-life case studies. InformedDNA is the authority on the appropriate use of genetic testing and the leading telemedicine provider of clinical genetics services. 

Who should attend? Anyone involved in designing or operating clinical trials for rare disease therapies. Register now.

Bioavailability Toolkit
FierceMarkets Custom Publishing

This industry survey seeks to gain insight on the drug developer’s perspective on bioavailability enhancement technologies and the reasoning behind the use of certain technologies over others in preclinical and early-stage clinical development. Take the survey for a chance to win a $5 Amazon gift card.

Leads Discovered: Accelerating Drug Discovery with Novel Tools for Structure & Sequence Activity Relationship Analysis
April 22, 2020 | 11am ET / 8am PT | PerkinElmer

As Biologics and sequence-based therapeutics become more pervasive, a new set of Sequence-Activity-Relationship tools are gaining importance in drug discovery. This webcast will showcase how AbbVie has been working with PerkinElmer solutions that extend their SAR analysis capabilities to include both small molecules and biologics in a single extensible platform that promises to expedite the lead discovery process. Click here to register.

Drug Product Advancement – A Path Through Development by Powder in Capsule Approach
April 14, 2020 11 a.m. EST / 8 a.m. PST | Lonza

Using micro-dosing technology and powder-in-capsule (PIC) or bottle (PIB) approaches, biopharmaceutical companies have the ability to increase speed to clinic, quickly assess their candidate compounds, and remain cost-conscious in early stage development.  Attendees working with an oral solid dosage development and manufacturing will benefit from this educational webinar.  This webinar will also be informative to attendees with responsibilities for rapid first-in-human studies with oral solid drug product. Register now.

Clinical Trial Data meets the Real World: Bridging the Experimental and Post-Launch Worlds
April 2, 2020 2 p.m. EST / 11 a.m. PST | Acorn AI by Medidata

This webinar will address key considerations and best practices when combining clinical trial data with real world data to power big data analytics. Register now.

Veeva 2020 Unified Clinical Operations Survey

The Veeva 2020 Unified Clinical Operations Survey examines the life sciences industry’s progress in reducing system and process complexity to improve study execution and simplify how study partners work together throughout the trial lifecycle. The goal of this research is to understand the drivers, benefits, and barriers of a unified and connected clinical operating model.

Please share your opinion in this 10-minute survey.  All qualified respondents will be entered to win a $500 Amazon gift card.

Data Analytics in Life Sciences: 2020 State of the Industry Survey
FierceMarkets Custom Publishing

The life sciences industry has always relied upon empirical data and analytics to inform product development activities and commercial strategies. The goal of this research is understand the drivers, benefits and barriers to scaling analytics across all facets of a life sciences organization’s operations.

Begin the survey for a chance to be one of 50 qualified respondents to receive a $5 Amazon gift card.

[eBook] Expecting the Unexpected: Strategies for Efficient Clinical Supply Management and Forecasting

Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Click here to download the eBook.

Coronavirus Virtual Series
March 30 - April 1, 2020 | FierceHealthcare and FiercePharma

FiercePharma and FierceHealthcare bring you a week of virtual updates and expert panels discussing the coronavirus. We're assembling a series of experts to discuss industry’s role in preparing for a pandemic and what steps can be taken to mitigate risk while dealing with the outbreak. Register for sessions now.

Before GLP: The Value of Robust Exploratory Toxicology Prior to Pivotal GLP Studies
Recorded on: March 26, 2020 | Frontage Laboratories

The webinar on March 26 is “Before GLP: The value of robust exploratory toxicology prior to pivotal GLP studies.”  Mr. Ryan will share experiences and stories, as well as suggestions for how to set up a successful IND approach.  We hope you will find our discussion insightful and help you avoid unexpected surprises in your IND-directed studies. Register to save your spot today!

Managing the Risks of Implementing E6R2
Recorded on: March 25, 2020 | Rho

Successful implementation of RBQM is a challenge many in our industry are facing. To understand what it is and how it impacts the management of your clinical trial, this webinar will address what exactly E6R2 is. We will use Rho as a case study for designing and implementing a strategy, discuss common misconceptions, and review lessons Rho has learned through implementation of RBQM. Click here to register for this webinar today!

Accelerate Clinical Operations Across Sponsors, CROs and Partners With a Best-of-Breed Partner Like Box
Aired on: March 24, 2020 | Box

Learn how Box is a critical force multiplier in the Best-of-Breed application stack with partners like Nintex, DocuSign and Slack in supporting clinical operations for both regulated and non-regulated content. Register now.

Thermo Fisher Scientific Invests $800 Million to Help Biopharma and Pharma Companies Accelerate Commercialization and Bring Medicines to Patients Faster
Recorded on March 23, 2020 | Patheon

Join Thermo Fisher Scientific for a live webcast on its $800 million investments in its biologics, cell and gene therapy, and drug product capabilities to help biopharma and pharma companies of all sizes accelerate commercialization and bring medicines to patients faster.

Paid Marketplace
How Can Extrusion Benefit your Pharmaceutical Oral Drug Product?

As a continuous manufacturing process, extrusion was cemented in pharmaceutical manufacturing in 1980s with market launch of sustained-release Verapamil, which contains embedded crystalline active pharmaceutical ingredient (API) in polymers. Following the Verapamil launch, researchers have turned to hot melt extrusion (HME) as an effective enabling technology to manufacture amorphous solid dispersions (ASDs) for poorly soluble compounds.

Click here to learn more.

Paid Marketplace
[Fact Sheet] Forecasting to Optimize Clinical Trial Supply Management

Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Download the Fact Sheet here.

Advanced Dosage Forms: How and Why Companies are Rethinking Drug Formulation

To better understand industry perspectives on the dosage forms, Catalent and FiercePharma surveyed 262 pharmaceutical leaders in 2019 to gather the views of individuals who have recently been involved in the development of oral dosage forms. Download this infographic to learn more about survey results and expert insight on trends uncovered by the survey.

Ensuring the Greatest Return From Your Poorly Soluble Molecule
Patheon, by Thermo Fisher Scientific

Improving the solubility of a compound can be challenging and frustrating. Consider these potential solutions to overcome any solubility hurdles: solid dispersions, salt formation, lipid formulations, inclusion complexes, nanocrystals, and a wide variety of other technologies. Click here to download the whitepaper!

Use Serialization Data to Maximize Performance and Minimize Risks
March 18, 2020 11 a.m. EST / 9 a.m. PST | Systech

Serialized products generate a wealth of data as they move through the supply chain. What if you could access and analyze this data to gain operational visibility and powerful business insight? It’s time to put your serialization investment to work for you. Learn how in this webinar.

Paid Marketplace
Capsugel® Quality

Not all capsules are created equal …

Capsugel® has a global network of manufacturing facilities, which are routinely inspected by regulatory authorities, customers and our own internal audit teams. We work diligently every day to ensure the strictest industry standards for our products.  Learn more.

Artificial Intelligence in the Pharma Industry

Obtaining feedback from Life Sciences organizations are key in the delivery of actionable insights that our target customers come to expect. Our goal is to assess how far the adoption of AI technology has come in Life Sciences. Complete the survey for a chance to be one of 50 qualified respondents to receive a $5 Amazon gift card.

Translational Modeling Strategies to Predict Clinical Doses for CD3 Bispecific Molecules
Recorded on: March 12, 2020 | Applied BioMath

Learn how a Quantitative Systems Pharmacology (QSP) model and translational framework described for CD3 bi-specific molecules provides a holistic solution for quantitative decision making throughout the drug discovery and development process. Register now.

Paid Marketplace
[Case Study] Establishing Parameters for Success

Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Click here to download the Case Study.

Paid Marketplace
What's the value of an MBA to healthcare and the life sciences?
Global EMBA for Healthcare & the Life Sciences, University of Toronto

18 months, 4 countries. Your leadership, transformed through the Global Executive MBA for Healthcare and the Life Sciences at the University of Toronto. Prepare to step up in your career, build the expertise you need to reshape your organization, and explore opportunities worldwide. Download the guide. 

Measure the Right Things at the Right Time: Using A Metric Maturity Model to Optimize Performance Measurement
WCG Metrics Champion Consortium

How does your organization measure clinical trial performance? Does it measure the right things? Does it measure them effectively? Ineffective measurement could mean wasting both time and money. This whitepaper showcases a custom-built Metric Maturity Model that helps illustrate and define the process for measuring the right things the right way.  Download the whitepaper

Create A More Compelling Program Development Dossier With Metabolomics

Metabolomics can help you streamline your drug development process by providing the framework to make a stronger, more confident, and more valuable case for a molecule in a shorter timeframe. Learn more.

Manufacturing Cytotoxic and Non-Cytotoxic

When different drug products are produced in shared facilities, potential for cross-contamination needs to be addressed.  Outsourcing to a CMO with experience in multiproduct facilities can be an option. Download the whitepaper.

9 Ways to Enhance Healthcare Customer Experiences

Customers demand more from their marketing—and healthcare brands are no exception. Is your brand providing the customer experiences that patients, providers and hospital administrators expect? Find out in our new e-book.

Are You Prepared for the Future of Clinical Development?
IBM Watson Health

The world of life sciences is evolving. The industry is poised to transition to modern, technology-driven methods that can produce faster results with higher quality. This whitepaper will explore the advantages and challenges of adopting these new approaches. Download now.

Accelerating Approval for Cell and Gene Therapies
Recorded on: February 27, 2020 | Cardinal Health

Developers of cell and gene therapies can run into complex clinical and regulatory hurdles when bringing treatments to patients. Join experts from Cardinal Health Regulatory Sciences to explore critical factors that can help reduce the risk of failure and increase speed to market. Register for this webinar today!

Tufts-eClinical Solutions Data & Analytics Survey Results
Recorded on: February 26, 2020 | eClinical Solutions

Key findings from the 2019 Life Sciences Data & Analytics Survey conducted by the Tufts Center for the Study of Drug Development will be unveiled during this live webinar led by industry expert and study lead, Ken Getz, Director of Sponsored Programs and Associate Professor. Watch On Demand Now!

Patient Centric Healthcare - The Role of AI and Data Science

Patients are enjoying greater choice and simplicity in their daily lives. Whether it’s listening to curated playlists on Spotify or being recommended their new favorite movie on Netflix. Healthcare providers must keep pace with these changing consumer demands. Our latest whitepaper explores how new technologies and AI developments are allowing businesses in the healthcare sector to keep up with patients’ heightened expectations. Download your copy. 

Navigating Today’s Healthcare Transformation: The Evolution of Payers
The Kinetix Group

As the healthcare landscape is evolving to value-based care, payers are implementing new strategies to adapt to this environment. TKG met with payer advisors to learn more about what these stakeholders are doing to improve healthcare for patients, enhance efficiencies for providers, and reduce costs for themselves. Download the whitepaper.

Navigating HUB Design in 2020: Insource vs. Outsource vs. Hybrid
Archbow Consulting

Current industry trends are creating a shift in how manufacturers are approaching their HUB programs. Download this whitepaper to explore a variety of factors to consider when choosing between insourced, outsourced, and hybrid HUB models.

Executive Summary
[Executive Summary] Strategies for Flexible Manufacturing

This whitepaper discusses the benefits of end-to-end solutions and share case studies on how flexible manufacturing strategies can accommodate the changing landscape of pharmaceutical products and help bring a drug to market. Click here to download the executive summary!

Successful BYOD in Any Phase
Clinical Ink

The biggest challenge facing clinical research today is the need to gather, analyze, and report data. To collect patient data more efficiently, researchers are increasingly exploring BYOD strategies for their trials; that is, allowing patients to utilize their own devices to collect data within the context of a clinical trial.

Our white paper discusses BYOD advantages and misconceptions, regulatory, copyright, and equivalency considerations, and a Phase III case study. Read now and consider a BYOD ePRO approach for your next clinical trial.

Understanding the New MDR Article 117 and its Impact on Combination Product Applicants and Medical Device Constituent Part Supplier
February 13, 2020 11 a.m. EST / 8 a.m. PST | West Pharmaceutical Services, Inc.

Understanding the medical device design and how it forms integral and non-integral drug device combinations (DDC’s)  is critical to navigate the new European regulatory landscape.Examples of these expectations will be presented to outline the overall impact of Article 117 and additional elements of the MDR 2017/745 pertaining to combination drug products as regulated within the European community.  Register now.

InCrowd’s 2020 Healthcare Predictions
Recorded on: February 11, 2020 | InCrowd

How will 2020 change US healthcare? InCrowd’s physicians weigh in on what the new year will bring. Join Diane Hayes, PhD, InCrowd Co-Founder and Board Member and Daniel S. Fitzgerald, InCrowd CEO and President, for InCrowd’s 2020 Healthcare Predictions Webinar. Register Now!

Innovation in OTC Products: A survey report on why it matters and how to achieve it

To better understand why innovation is important to the OTC industry and how it is achieved, Catalent and FiercePharma conducted a survey which generated responses from 233 people from the OTC industry. Download this infographic to learn more about survey results and expert insight on trends uncovered by the survey.

Model-Based Approach to Design Bi-Specific Modalities in Early Discovery
Recorded on: February 4, 2020 | Applied BioMath

Learn how we used a tiered model-based approach of a bi-specific antibody to appropriately cover multiple antigen pairs to help teams with informed antibody design, prioritization of experiments, and triaging of challenging antigen pairs.  Register today.

5 Ways to Make Monitoring More Efficient
Recorded on January 30, 2020 | Veeva

This new year, take a fresh look at your monitoring processes and learn how to improve efficiency across the entire monitoring lifecycle. Register for the webinar here.

Cartridge Based Drug Delivery…Evolving Technologies Designed With the Patient in Mind.
Recorded on January 28, 2020 | West Pharmaceutical Services, Inc.

The focus of this webinar will be on the design and process approach for next generation large volume delivery systems for prefilled cartridge delivery, as well as on providing an overview of key critical product requirements, such as compatibility with sensitive drug products, system functionality, and fill-finish implementation. Register now.

Perceptions, Myths & New Thinking on Direct-to-Patient Clinical Supply
Recorded on January 23, 2020 | Catalent

This webinar reveals results from a recent industry survey that sought to gain insight on trial sponsors’ perspective on offering a DTP option and their current level of awareness and understanding of any factors that may influence their ability to do so. Register now to learn more.

Executive Summary
[Executive Summary] Overcoming Manufacturing Challenges for Accelerated Drug Development

Regardless of the assigned FDA expedited approval designation and approach, the key action items should be: the assurance of a detail-oriented plan and the adaption of a “forward-thinking” approach that will assist in any future challenges and opportunities for growth of each project. Click here to download the Executive Summary.

Paid Marketplace
[Presentation] Flexible Manufacturing Strategies

Get expert insights on strategies to implement flexible manufacturing and different technologies that are easily scalable and reproducible. Click here to download the presentation.

The Art of Recognizing Clinical Supply Risk Factors and Applying Proactive Measures Avoid Study Delays and Disruptions
Recorded on January 14, 2020 | Catalent

Are there certain types of clinical sponsors and studies that are at greater risk of experiencing supply challenges? This webinar will explore aspects of the study protocol that can directly influence clinical supply strategy and how sponsors can proactively understand and address clinical supply-related risks. Register now.

Paid Marketplace
Online Graduate Programs Designed for Your Career
Drexel University Online

Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career.  Learn more.

Transportation Solutions for Cell & Gene Therapy Supply Chains
Recorded on December 17, 2019 | Thermo Fisher Scientific

From the basics such as service level expectations for couriers versus integrators, to how to evaluate domestic and international lanes, and finally – how to balance risk and cost, this webinar will help you understand how to start tackling your clinical supply chain. Register now.

Digital Medicine 101
Recorded on December 12, 2019 | Amazon Web Services

Join us as an interdisciplinary group of experts from the Digital Medicine Society (DiMe) provide a brief introduction to core concepts and terms that define digital medicine, along with practical tips for implementation and case examples. 

Medical Devices and Advanced Analytics: Delivering on the Promise of Connected Data
Recorded on December 11, 2019 | Medidata

Today, the rise of a new generation of robotic, precision, and surgical devices has created vast stores of video, imaging, and electronic surgical notes, prompting the question: How do you leverage these datasets and improve patient treatments and outcomes? Register now to learn how a connected data platform offers a definitive answer. 

Digital Twins: Creating Digital Operations Today to Deliver Business Value Tomorrow

This white paper highlights the challenges of implementing the right digital twin strategy while providing use cases in manufacturing with highest impact in terms of expected return, and a vision of technology trends shaping the future of digital twins. Click here to download the whitepaper.


Connecting Primary Container Systems with Excipient Evaluation During Drug Development
Recorded on December 5, 2019 | West Pharmaceutical Services, Inc.

Why should the primary container system be considered an excipient? Register for West’s webinar on December 5, to gain insight on considerations that should be made to mitigate packaging risks early in the drug development process! 

Planning a Rapid Commercial Market Launch for Your Biologic
Recorded on December 4, 2019 | Catalent

In this webinar, AstraZeneca and Catalent Biologics experts will share a case study on a 30-day commercial launch plan for a product into new markets and why this approach was important for patients. Register now.

How ICON, Lotus, and Bioforum are Improving Study Efficiency with a Modern EDC
Recorded on December 3, 2019 | Veeva

Hear how ICON, Lotus Clinical Research, and Bioforum are speeding database builds and automating reporting tasks for data management.  Learn how to reap the rewards of a straightforward build and a modern EDC during this webinar. Register now.

Prescription Drug Pricing: How Lack of Transparency Reduces Market Access, Utilization, and Adherence

It's clear that healthcare prices weigh heavily on the minds of Americans, and the time has come for the pharmaceutical industry to take the reins of the prescription drug pricing dialogue with consumers. Download this whitepaper now to learn more about prescription drug price transparency and its role in creating affordability, accessibility, and accountability.

Driving Patient Innovation Through Software as a Medical Device
Recorded on November 21, 2019 | Accenture

Accenture experts will explore the emergence of SaMD as a new class of medical device and discuss the potential challenges that biopharma companies face in the development of these solutions. Register for this webinar now.

Striving for Zero in Quality & Manufacturing
Recorded on November 19, 2019 | OpenText

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. At the same time, they must meet GxP requirements, update antiquated systems and processes, and address the demands of an increasingly tech savvy workforce. Register now to learn more about the role that content management plays in pharmaceutical manufacturing.

Tackling Clinical Trial Data Overload with Data Lakes and Machine Learning

This whitepaper explores how a data lake, enabled by AI and ML, can be used to ingest, aggregate, standardize and provide secured data access and the value it can deliver in reducing risk and driving efficiency, speed and cost savings. Download now.

OTC Innovation to Avoid Stagnation: Survey Insights, Expert Advice, and Latest Technologies to Boost Your Product’s Performance
November 13, 2019 | 11am ET / 8am PT | Catalent

Join industry experts as they analyze the critical role of innovation in OTC products, and strategies for achieving it. Register now to learn more about survey insights, market trends, and latest technologies.

Lipid-based Formulations for Early Stage Clinical Trials
November 13, 2019 | 10am ET / 7am PT | Lonza

Liquid-filled capsule technology has a proven record for addressing complex API formulation challenges, but also offers a simple and effective pathway to the clinic. Register now to learn more about lipid-based formulations.